Literature DB >> 22595270

Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.

Maria Grazia Ammendolia1, Mariangela Agamennone, Agostina Pietrantoni, Fabio Lannutti, Rosa Anna Siciliano, Beatrice De Giulio, Carla Amici, Fabiana Superti.   

Abstract

Bovine lactoferrin (bLf) is a multifunctional glycoprotein that plays an important role in innate immunity against infections, including influenza. Here we have dissected bLf into its C- and N-lobes and show that inhibition of influenza virus hemagglutination and cell infection is entirely attributable to the C-lobe and that all major virus subtypes, including H1N1 and H3N2, are inhibited. By far-western blotting and sequencing studies, we demonstrate that bLf C-lobe strongly binds to the HA(2) region of viral hemagglutinin, precisely the highly conserved region containing the fusion peptide. By molecular docking studies, three C-lobe fragments were identified which inhibited virus hemagglutination and infection at fentomolar concentration range. Besides contributing to explain the broad anti-influenza activity of bLf, our findings lay the foundations for exploiting bLf fragments as source of potential anti-influenza therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595270      PMCID: PMC4001507          DOI: 10.1179/2047773212Y.0000000004

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  48 in total

1.  Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides.

Authors:  Agostina Pietrantoni; Assunta Maria Di Biase; Antonella Tinari; Magda Marchetti; Piera Valenti; Lucilla Seganti; Fabiana Superti
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 2.  Microbial contaminants and antimicrobial properties of human milk.

Authors:  J T May
Journal:  Microbiol Sci       Date:  1988-02

Review 3.  Influenza pandemic epidemiologic and virologic diversity: reminding ourselves of the possibilities.

Authors:  Eric J Kasowski; Rebecca J Garten; Carolyn B Bridges
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 6.  A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.

Authors:  Nicasio Mancini; Laura Solforosi; Nicola Clementi; Donata De Marco; Massimo Clementi; Roberto Burioni
Journal:  Antiviral Res       Date:  2011-07-21       Impact factor: 5.970

7.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

8.  Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection.

Authors:  Hitomi Sano; Kazushige Nagai; Hiroyuki Tsutsumi; Yoshio Kuroki
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

9.  Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.

Authors:  Magda Marchetti; Edward Trybala; Fabiana Superti; Maria Johansson; Tomas Bergström
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

10.  Replication and plaque assay of influenza virus in an established line of canine kidney cells.

Authors:  C R Gaush; T F Smith
Journal:  Appl Microbiol       Date:  1968-04
View more
  26 in total

1.  Infection and Replication of Influenza Virus at the Ocular Surface.

Authors:  Hannah M Creager; Amrita Kumar; Hui Zeng; Taronna R Maines; Terrence M Tumpey; Jessica A Belser
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

2.  Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding.

Authors:  Henry Memczak; Daniel Lauster; Parimal Kar; Santiago Di Lella; Rudolf Volkmer; Volker Knecht; Andreas Herrmann; Eva Ehrentreich-Förster; Frank F Bier; Walter F M Stöcklein
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

Review 3.  The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy.

Authors:  I-Ni Hsieh; Kevan L Hartshorn
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-06

4.  Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.

Authors:  Maria Carmina Scala; Marina Sala; Agostina Pietrantoni; Antonia Spensiero; Simone Di Micco; Mariangela Agamennone; Alessia Bertamino; Ettore Novellino; Giuseppe Bifulco; Isabel M Gomez-Monterrey; Fabiana Superti; Pietro Campiglia
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

5.  VEN-120, a Recombinant Human Lactoferrin, Promotes a Regulatory T Cell [Treg] Phenotype and Drives Resolution of Inflammation in Distinct Murine Models of Inflammatory Bowel Disease.

Authors:  Christopher F MacManus; Colm B Collins; Tom T Nguyen; Randall W Alfano; Paul Jedlicka; Edwin F de Zoeten
Journal:  J Crohns Colitis       Date:  2017-09-01       Impact factor: 9.071

6.  Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study.

Authors:  Clare Dix; Olivia Wright
Journal:  Nutrients       Date:  2018-08-17       Impact factor: 5.717

7.  C-lobe of lactoferrin: the whole story of the half-molecule.

Authors:  Sujata Sharma; Mau Sinha; Sanket Kaushik; Punit Kaur; Tej P Singh
Journal:  Biochem Res Int       Date:  2013-05-15

8.  Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.

Authors:  Elrashdy M Redwan; Esmail M El-Fakharany; Vladimir N Uversky; Mustafa H Linjawi
Journal:  BMC Complement Altern Med       Date:  2014-07-03       Impact factor: 3.659

Review 9.  Perspective of Use of Antiviral Peptides against Influenza Virus.

Authors:  Sylvie Skalickova; Zbynek Heger; Ludmila Krejcova; Vladimir Pekarik; Karel Bastl; Jozef Janda; Frantisek Kostolansky; Eva Vareckova; Ondrej Zitka; Vojtech Adam; Rene Kizek
Journal:  Viruses       Date:  2015-10-20       Impact factor: 5.048

10.  Bovine Lactoferrin Prevents Influenza A Virus Infection by Interfering with the Fusogenic Function of Viral Hemagglutinin.

Authors:  Fabiana Superti; Mariangela Agamennone; Agostina Pietrantoni; Maria Grazia Ammendolia
Journal:  Viruses       Date:  2019-01-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.